Table 1.
Name | Exogenous Chemotherapy Substance |
---|---|
MDR1, ABCB1, P-GP | Anthracyclines (doxorubucin, daunorubicin, epirubicin), actinomycin D, colchicine, podophyllotoxin (etoposide, teniposide), methotrexate (only in carrier-deficient cells), mitomycin C, mitoxantrone, taxenes (paclitaxel, docetaxel), vinca alkaloids (vincristine, vinblastine) |
MRP1, ABCC1 | Anthracyclines, cochicine, etoposide, heavy metals (arsenite, arsenate, antimonials), vincristine, vinblastine, paclitaxel |
MRP2, ABCC2, cMOAT | Cisplatin, CPT-11, doxorubicin, etoposide, methotrexate, SN-38, vincristine, vinblastine |
MRP3, ABCC3 | Cisplatin, doxorubicin, etoposide, methotrexate, teniopside, vincristine |
MRP4, ABCC4 | Methotrexate, nucleotide analogs, PMEA * |
MRP5, ABCC5 | Doxorubicin, methotrexate, nucleotide analogs, topotecan |
MRP6, ABCC6 | Doxorubicin, etoposide, teniposide |
MRP8, ABCC11 | 5′-Fluorouracil, 5′-fluoro-2′-deoxyuridine, 5′-fluoro-5′-deoxyuridine, PMEA* |
BCRP, ABCG2, MXR1, ABCP | Anthracyclines, bisantrene, camptothecin, epirubicin, flavopiridol, mitoxantrone, S-38, topotecan |
* PMEA: 2′,3′-dideoxycytidine 9′-(2′-hosphonylmethoxynyl)adenine.